Proteomics Market 2020: Global Industry Exhibits Huge Growth by Top Key Players
Proteomics is a science which is used to estimate the rate
of protein production, interaction of proteins with one another, involvement of
proteins in metabolic pathways, and modification of proteins. Also, it has
extensive applications in drug discovery, development of personalized
medicines, and identification of markers for disease diagnosis.
The Global Proteomics
Market is anticipated to hold a market value of USD 23.2 billion in the
year 2017 and is expected to grow at a CAGR of 14.1% during the forecast
period. Increasing need for personalized medicine, R&D expenditure,
technological advancements and increased funding for proteomics project are expected
to drive the market growth over the forecast period. For instance, in July
2017, Biognosys AG received USD 5 million funding from its new as well as
existing investors. These new funds will be used for extending commercial
operations and also to accelerate the development of next generation proteomics
workflows. However, reduced funding in
key markets of proteomics, high cost of tools & equipment and lack of
skilled researchers can restrain the market growth over the assessment period.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6930
Key Players:
Some of the prominent players in the global proteomics
market are GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher,
Siemens Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Inc.,
Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA,
PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and Others.
Segmentation (largest & fastest):
The global proteomics market has been segmented into
equipment, services and application.The market, on the basis of equipment, has
been segmented into chromatography, mass spectroscopy, protein microarray,
X-ray crystallography, protein fractionation and others.The global market, on
the basis of services, has been segmented into laboratory services and data
analysis & services.
The global proteomics market, by application, has been
segmented into drug discovery, clinical diagnosis and others. The clinical
diagnosis segment is expected to hold the largest market share owing to the
increased understanding of the relevance of investigating and understanding
patterns of protein expression for diseases & drug development. The drug
discovery segment is anticipated to grow at the fastest CAGR owing to
continuous search for alternative & efficient methods to deliver enhanced
drugs and increased R&D investments by pharmaceutical & biotechnology
companies.
Regional Analysis:
Geographically, the Americas is expected to dominate the
global market owing to the easy availability of funds from various
organizations and rising interest in personalized medicines. According to the
Personalized Medicine Coalition, number of available personalized medicines
increased to 113 in 2014 from 13 in 2006. Europe is expected to hold the second
largest position in the global market owing to the rising cancer research
activities and high funding from the government. Asia-Pacific is expected to be
the fastest growing market owing to the high prevalence of cancer and rising
healthcare expenditure. Moreover, the Middle East and Africa region is expected
to account for the least market share in the global market.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/proteomics-market-6930
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment